Antiretroviral treatment induces a shift to type-2 cytokine responses in HIV-1 infected pregnant women

European Cytokine Network

Volumn 11, Issue 4, 2000, Pages 647-653

  Alonso, R ^a   Resino, S ^a   Bellon J M ^a   Munoz Fernandez M A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Antiretroviral treatment; Cytokine; HIV 1 pregnancy; Zidovudine

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 5; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PREGNANCY; T LYMPHOCYTE;

ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTE SUBSETS; TH2 CELLS; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034517592     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV
2. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
3. Zidovudine treatment prevents vertical transmission of human immunodeficiency virus-1 independently of viral load
4. Maternal viral load and vertical transmission of HIV-1: An important factor but not the only one
5. Th1-type immunity is incompatible with successful pregnancy
6. Host factors and the pathogenesis of HIV-induced disease
7. Replication of human immuno-deficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation
8. Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells
9. A Th1 → Th2 switch is a critical step in the etiology of HIV infection
10. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals
11. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection
12. Maternal human immunodeficiency virus-1 infection and pregnancy outcome
13. Perinatal outcome in HIV-infected pregnant women
14. Immunological contributions to recurrent pregnancy loss
15. What do we know about spontaneous abortion mechanisms?
16. T helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion
17. Role of placental cytokines and inflammation in vertical transmission of HIV infection
18. Revised classification system for HIV-1 infection and expanded surveillance case definition for AIDS among adolescent and adults
19. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection
20. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
21. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load
22. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes
23. Cytokine modulation of HIV expression
24. Bidirectional cytokine interactions in the maternal-foetal relationship: Is successful pregnancy a Th2 phenomenon?
25. Effects of perinatal zidovudine on hematopoiesis: A comparison of effects on progenitors from human fetuses versus mothers
26. Zidovudine pharmacokinetics during pregnancy
27. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates
28. Dinámica de producción de inmunoglobulinas en ninõs no infectados nacidos de madres infectadas por el VIH-1: Efecto de la zidovudina